{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T22:47:31Z","timestamp":1794523651978,"version":"4.9.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004033","name":"Johannes Gutenberg-Universit\u00e4t Mainz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.compbiomed.2023.106781","type":"journal-article","created":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T01:53:25Z","timestamp":1678499605000},"page":"106781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["A drug repurposing approach for individualized cancer therapy based on transcriptome sequencing and virtual drug screening"],"prefix":"10.1016","volume":"157","author":[{"given":"Onat","family":"Kadioglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faranak","family":"Bahramimehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Dawood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuha","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elbadawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yagmur","family":"B\u00fclb\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana Agnieszka","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Kathrin","family":"Urschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"K\u00fcnzli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Abdulrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadwa","family":"Aboumaachar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lajien","family":"Kadalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Van","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Shaidaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawal","family":"Thaher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolin Christiane","family":"Besler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Spuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4947-8796","authenticated-orcid":false,"given":"Markus","family":"Munder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry Johannes","family":"Greten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Efferth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2023.106781_bib1","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cancers6031769","article-title":"Drug resistance in cancer: an overview","volume":"6","author":"Housman","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.compbiomed.2023.106781_bib2","first-page":"141","article-title":"Drug resistance and combating drug resistance in cancer","volume":"2","author":"Wang","year":"2019","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.compbiomed.2023.106781_bib3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/carcin\/bgt086","article-title":"A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments","volume":"34","author":"Masui","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.compbiomed.2023.106781_bib4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/sj.bjc.6603885","article-title":"Targeting EGFR and HER-2 with cetuximab- and trastuzumab-mediated immunotherapy in oesophageal squamous cell carcinoma","volume":"97","author":"Kawaguchi","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.compbiomed.2023.106781_bib5","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S1470-2045(14)70342-0","article-title":"Dual targeting of HER2 with lapatinib and trastuzumab","volume":"15","author":"Joensuu","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.compbiomed.2023.106781_bib6","article-title":"Targeting CD20+ B-lymphocytes in inflammatory dilated cardiomyopathy with rituximab improves clinical course: a case series","volume":"3","author":"Tschope","year":"2019","journal-title":"Eur Heart J Case Rep"},{"key":"10.1016\/j.compbiomed.2023.106781_bib7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1586\/era.09.6","article-title":"Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab","volume":"9","author":"Finn","year":"2009","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.compbiomed.2023.106781_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2015.07.010","article-title":"A historical overview of protein kinases and their targeted small molecule inhibitors","volume":"100","author":"Roskoski","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.compbiomed.2023.106781_bib9","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41591-019-0407-5","article-title":"Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study","volume":"25","author":"Sicklick","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.compbiomed.2023.106781_bib10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13073-019-0703-1","article-title":"Molecular profiling for precision cancer therapies","volume":"12","author":"Malone","year":"2020","journal-title":"Genome Med."},{"key":"10.1016\/j.compbiomed.2023.106781_bib11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.semcancer.2019.07.010","article-title":"RNA sequencing for research and diagnostics in clinical oncology","volume":"60","author":"Buzdin","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.compbiomed.2023.106781_bib12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13045-020-01005-x","article-title":"RNA sequencing: new technologies and applications in cancer research","volume":"13","author":"Hong","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.compbiomed.2023.106781_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/v12091058","article-title":"Drug repositioning: new approaches and future prospects for life-debilitating diseases and the COVID-19 pandemic outbreak","volume":"12","author":"Low","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.compbiomed.2023.106781_bib14","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/jphp.13273","article-title":"Drug repositioning: a brief overview","volume":"72","author":"Jourdan","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.compbiomed.2023.106781_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.596697","article-title":"Safety and efficacy of adjunctive therapy with artesunate in the treatment of severe malaria: a systematic review and meta-analysis","volume":"11","author":"Zou","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.compbiomed.2023.106781_bib16","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/cid\/ciab133","article-title":"Intravenous artesunate for the treatment of severe imported malaria: implementation, efficacy, and safety in 1391 patients","volume":"73","author":"Roussel","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.compbiomed.2023.106781_bib17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ebiom.2014.11.010","article-title":"A randomised, double blind, placebo-controlled pilot study of oral artesunate therapy for colorectal cancer","volume":"2","author":"Krishna","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.compbiomed.2023.106781_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.phymed.2017.11.003","article-title":"Cancer combination therapy of the sesquiterpenoid artesunate and the selective EGFR-tyrosine kinase inhibitor erlotinib","volume":"37","author":"Efferth","year":"2017","journal-title":"Phytomedicine"},{"key":"10.1016\/j.compbiomed.2023.106781_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-047147","article-title":"Evaluation of artesunate-mefloquine as a novel alternative treatment for schistosomiasis in African children (SchistoSAM): protocol of a proof-of-concept, open-label, two-arm, individually randomised controlled trial","volume":"11","author":"Roucher","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.compbiomed.2023.106781_bib20","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jaad.2020.07.069","article-title":"Identification of potential inhibitors targeting BRAF-V600E mutant melanoma cells","volume":"84","author":"Kadioglu","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.compbiomed.2023.106781_bib21","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s10637-020-01037-7","article-title":"Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma","volume":"39","author":"Saeed","year":"2021","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.compbiomed.2023.106781_bib22","doi-asserted-by":"crossref","first-page":"512","DOI":"10.21873\/cgp.20337","article-title":"Protein expression profiling and virtual drug screening as an approach for individualized therapy of small cell vaginal carcinoma","volume":"19","author":"Saeed","year":"2022","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.compbiomed.2023.106781_bib23","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1186\/s13063-019-3664-1","article-title":"Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols","volume":"20","author":"Park","year":"2019","journal-title":"Trials"},{"key":"10.1016\/j.compbiomed.2023.106781_bib24","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","article-title":"The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers","volume":"18","author":"Sondka","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.compbiomed.2023.106781_bib25","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the Catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2023.106781_bib26","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.compbiomed.2023.106781_bib27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jchf.2018.09.001","article-title":"Long-term risk of heart failure in breast cancer patients after adjuvant chemotherapy with or without trastuzumab","volume":"7","author":"Banke","year":"2019","journal-title":"Jacc-Heart Fail"},{"key":"10.1016\/j.compbiomed.2023.106781_bib28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12935-015-0221-1","article-title":"Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp","volume":"15","author":"Alfarouk","year":"2015","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.compbiomed.2023.106781_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2020.04.019","article-title":"Conceptual framework for precision cancer medicine in Germany: consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'","volume":"135","author":"Westphalen","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.compbiomed.2023.106781_bib30","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ijc.32133","article-title":"Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: analysis of the first 3,000 Heidelberg cases","volume":"145","author":"Volckmar","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.compbiomed.2023.106781_bib31","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/ijc.30828","article-title":"Precision oncology based on omics data: the NCT Heidelberg experience","volume":"141","author":"Horak","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.compbiomed.2023.106781_bib32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13073-018-0529-2","article-title":"From somatic variants towards precision oncology: evidence-driven reporting of treatment options in molecular tumor boards","volume":"10","author":"Perera-Bel","year":"2018","journal-title":"Genome Med."},{"key":"10.1016\/j.compbiomed.2023.106781_bib33","article-title":"Computational drug repositioning: current progress and challenges","volume":"10","author":"Ko","year":"2020","journal-title":"Appl Sci-Basel"},{"key":"10.1016\/j.compbiomed.2023.106781_bib34","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3389\/fimmu.2019.00531","article-title":"Drug repurposing approaches for the treatment of influenza viral infection: reviving old drugs to fight against a long-lived enemy","volume":"10","author":"Pizzorno","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.compbiomed.2023.106781_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/srep36754","article-title":"Genomic and transcriptomic profiling of resistant CEM\/ADR-5000 and sensitive CCRF-CEM leukaemia cells for unravelling the full complexity of multi-factorial multidrug resistance","volume":"6","author":"Kadioglu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2023.106781_bib36","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","article-title":"dbSNP: the NCBI database of genetic variation","volume":"29","author":"Sherry","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2023.106781_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.compbiomed.2023.106781_bib38","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.compbiomed.2023.106781_bib39","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","article-title":"Strelka2: fast and accurate calling of germline and somatic variants","volume":"15","author":"Kim","year":"2018","journal-title":"Nat. Methods"},{"key":"10.1016\/j.compbiomed.2023.106781_bib40","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/bioinformatics\/btv710","article-title":"Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications","volume":"32","author":"Chen","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.compbiomed.2023.106781_bib41","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3389\/fphar.2018.00355","article-title":"Oridonin targets multiple drug-resistant tumor cells as determined by in silico and in vitro analyses","volume":"9","author":"Kadioglu","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.compbiomed.2023.106781_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104359","article-title":"Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning","volume":"133","author":"Kadioglu","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.compbiomed.2023.106781_bib43","doi-asserted-by":"crossref","first-page":"D1144","DOI":"10.1093\/nar\/gkaa1084","article-title":"Integration of the drug-gene interaction database (DGIdb 4.0) with open crowdsource efforts","volume":"49","author":"Freshour","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2023.106781_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110718","article-title":"Effect of ABC transporter expression and mutational status on survival rates of cancer patients","volume":"131","author":"Kadioglu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.compbiomed.2023.106781_bib45","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera- a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.compbiomed.2023.106781_bib46","first-page":"1","article-title":"Comparative protein structure modeling using MODELLER","volume":"86","author":"Webb","year":"2016","journal-title":"Curr Protoc Protein Sci"},{"key":"10.1016\/j.compbiomed.2023.106781_bib47","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1021\/acs.jctc.0c00121","article-title":"Extending the applicability of the ANI deep learning molecular potential to sulfur and halogens","volume":"16","author":"Devereux","year":"2020","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.compbiomed.2023.106781_bib48","doi-asserted-by":"crossref","DOI":"10.1063\/1.5023802","article-title":"Less is more: sampling chemical space with active learning","volume":"148","author":"Smith","year":"2018","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.compbiomed.2023.106781_bib49","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1021\/acs.jcim.7b00190","article-title":"A web application for protein preparation for molecular dynamics simulations","volume":"57","author":"Martinez-Rosell","year":"2017","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiomed.2023.106781_bib50","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1021\/acs.jctc.6b00049","article-title":"HTMD: high-throughput molecular dynamics for molecular discovery","volume":"12","author":"Doerr","year":"2016","journal-title":"J. Chem. Theor. Comput."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482523002469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482523002469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:02:53Z","timestamp":1757880173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482523002469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":50,"alternative-id":["S0010482523002469"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2023.106781","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A drug repurposing approach for individualized cancer therapy based on transcriptome sequencing and virtual drug screening","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2023.106781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106781"}}